Medical Device Warning Letters
The Forgotten Five of the Most Cited Observations

Wednesday, Oct. 9, 2019 • 1:30 p.m. - 3:00 p.m. EDT


Are you protected from the Forgotten Five most cited warning letter observations? If you’re not sure, you’re not alone.

Save your seat at this event to find solutions by understanding the Forgotten Five — the five highest-risk areas that prompt 483s and warning letters. The Forgotten Five are not frequently discussed and have not generated much corrective information. In other words, the Forgotten Five are the highest-risk areas that offer you the most potential to prevent inspection issues.

Dan O’Leary, President of Ombu Enterprises, LLC, is the perfect person to explain the Forgotten Five to you. Ombu maintains a database of all device warning letters from 2008 on. His firm’s analysis of this material has identified the Forgotten Five: the most frequently cited sections in the regulations with the least amount of information on how to deal with them. Addressing the Forgotten Five will give you the biggest impact for the effort.

This is your opportunity to adjust your processes to protect your business and ensure inspections go smoothly.

Webinar Takeaways:

  • The most commonly cited sections in warning letters
  • The distribution of warning letters by source, region and part
  • The Forgotten Five — the bottom 5 of the top 10 — most cited observations
  • The issues cited in the warning letters
  • How to address the issues before the inspection

Bonus! You’ll receive helpful checklists you can implement immediately for each of the Forgotten Five, effectively protecting your business against 483s and warning letters.

If you aren’t protecting your manufacturing processes against the Forgotten Five, you’re still highly vulnerable to 483s and warning letters. Change that by attending this webinar. Join us by registering today.

Who Will Benefit

  • Design Engineering Managers
  • Design Project Managers
  • Design Engineers
  • Quality Managers
  • Quality Engineers
  • Documentation Specialists
  • Regulatory Affairs Specialists

Webinar plus USB Audio Recording/Transcript
Learn more

$487

add to cart

Webinar only
Learn more

$287

add to cart

24/7 Encore plus USB Audio Recording/Transcript
Learn more

$487

add to cart

24/7 Encore Presentation
Learn more

$287

add to cart

USB Audio Recording/Transcript
Learn more

$287

add to cart

 

Meet Your Presenter

Dan O’Leary

President
Ombu Enterprises, LLC

Dan O’Leary is the President of Ombu Enterprises, LLC, a company offering training and execution in Operational Excellence, focused on analytic skills and a systems approach to operations management. Mr. O’Leary has more than 30 years’ experience in quality, operations and program management in regulated industries including medical devices and clinical laboratories. He has a Masters Degree in Mathematics; is an ASQ-certified Biomedical Auditor, Quality Auditor, Quality Engineer, Reliability Engineer and Six Sigma Black Belt; and is certified by APICS in Resource Management.

MII logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.

Phone (703) 538-7600 | Fax (703) 538-7676 | Toll free (888) 838-5578 | Email customerservice@fdanews.com

© 2019 FDAnews